Covaxin shows 50 per cent effectiveness against symptomatic COVID in real-world assessment: Lancet study Read more
Alembic Pharmaceuticals announces US FDA tentative approval for Dabigatran Etexilate capsules Read more
No scientific evidence to support need for booster vaccine dose against COVID, says ICMR chief Read more